Menlo Park, 5 December 2022 - Permira, the global private equity firm, today announced the appointment of Andy Eckert as a Senior Adviser to its global technology team, focusing on healthcare technology investments. He will also work with the firm’s healthcare team on broader opportunities in the sector.
Andy brings over 30 years of experience across the healthcare industry with proven expertise in managing and growing healthcare companies. He currently serves on the Board of Directors of Becton, Dickinson and Company (NYSE: BDX), a global medical technology leader, and was most recently CEO of Zelis, a payments technology and cost containment platform which aims to modernize the financial healthcare system. Andy also previously served as Chairman of the Board of Directors at Varian, a company dedicated to innovative cancer care that became part of Siemens Healthineers through a $16.4bn acquisition in 2021.
Prior to this, Andy was the CEO of Acelity, a global provider of wound care solutions and products. Under his leadership, Acelity accelerated top-line growth and was ultimately sold to 3M Corporation for $6.7bn. Andy has also served as CEO of numerous other healthcare companies including TriZetto, Valence Health, CRC Health Group, Eclipsys Corporation and SumTotal. He began his career at ADAC Laboratories, which included four years as Chairman and CEO until its sale to Philips Medical Systems.
At Permira, Andy will use his experience, network and wealth of knowledge to support investment activity in the healthcare technology space, a key vertical for Permira, and value creation across the funds’ portfolio companies. Andy will further strengthen the Permira team that has deployed more than €17.5bn in the technology sector and over €4.2bn in the healthcare sector to date.
Andy Eckert said: “I’m thrilled to be joining Permira, one of the leading private equity firms operating on a global scale. The healthcare industry is increasingly attractive for investment and Permira is well-positioned to be an important player in its technological transformation. I look forward to partnering with the healthcare and technology sector teams to find investment opportunities that will help drive innovation in healthcare globally.”
Ryan Lanpher, Technology Partner at Permira, and Silvia Oteri, Partner and Head of Healthcare at Permira, commented: “Andy brings a rare combination of knowledge and expertise in the healthcare, technology and healthtech sectors and we are thrilled to welcome him to the Permira family. Technology is playing an increasingly critical role in improving healthcare innovation and delivery, and we look forward to leveraging Andy’s experience to explore more collaborative investment opportunities in the space.”
Permira’s Senior Advisers help drive value by partnering with investment teams and management teams to both identify new opportunities and scale technology champions globally. Andy’s appointment follows the additions of tech industry veterans Koen Köppen, Simon Segars and Barry O’Sullivan earlier this year.